Clinical Trial

Therapy Optimisation for the Treatment of Hairy Cell Leukemia

Recruiting Phase 2/3
View on ClinicalTrials.gov →
Record status
This record was last updated August 22, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The trial will test the effectiveness and toxicity of subcutaneous treatment with one cycle of cladribine in patients with hairy cell leukemia requiring treatment. They have to be untreated so far or may be pretreated with alpha-interferon.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2014-05-02; most recent amendment 2024-08-20.
Trial Details
NCT Number NCT02131753
Lead Sponsor University of Giessen
Conditions Hairy Cell Leukemia
Enrollment 210 participants
Start Date 2004-05
Primary Completion 2025-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2024-08-22